RANBP3 and chronic myelogenous leukemia, BCR-ABL1 positive: Based on our data from cell experiments, to further explore the effect of RanBP3 on the pathogenicity of CML cells and chemo-sensitivity of IM in vivo, we constructed a CML mouse model.